# Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/association-of-tp53-mutations-with-response-and-longer-survival-under-immune/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sandra Assoun,Nathalie Théou–Anton,Marina Nguenang,Aurélie Cazes,Claire Danel,Baptiste Abbar,Johan Pluvy,V. Gounant,Antoine Khalil,Céline Namour,Solenn Brosseau,Gérard Zalcman |
| Citations | 173 |
| DOI | 10.1016/j.lungcan.2019.04.005 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.lungcancerjournal.info/article/S0169500219303927/pdf |
| OpenAlex ID | https://openalex.org/W2936661866 |
| PMID | 31097096 |
| Type | article |
| Year | 2019 |

## Paper authors

- [V. Gounant](https://scholariq.org/researchers/v-gounant/)

## Paper journal

- [Lung Cancer](https://scholariq.org/journals/lung-cancer/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.